A comprehensive view of HRA Pharma. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
FDA approves Opill tablet, the first daily oral contraceptive approved for use in US without a prescription; manufacturer HRA Pharma to determine product availability and pricing
Published:
July 13, 2023
by U.S. Food and Drug Administration (FDA)
|
Ask us about our Health Care Sector market view